Regional spread and control of vancomycin-resistant and in Kyoto, Japan

被引:27
作者
Matsushima, A. [1 ,2 ]
Takakura, S. [1 ,2 ]
Yamamoto, M. [1 ,2 ]
Matsumura, Y. [1 ,2 ]
Shirano, M. [1 ,2 ]
Nagao, M. [1 ,2 ]
Ito, Y. [3 ]
Iinuma, Y. [4 ]
Shimizu, T. [5 ]
Fujita, N. [6 ]
Ichiyama, S. [1 ,2 ]
机构
[1] Kyoto Univ Hosp, Dept Infect Control & Prevent, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Dept Clin Lab Med, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan
[3] Kyoto Univ, Dept Resp Med, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan
[4] Kanazawa Med Univ, Dept Infect Dis, Uchinada, Ishikawa 9200293, Japan
[5] Kyoto City Hosp, Dept Infect Dis, Nakagyo Ku, Kyoto 6048845, Japan
[6] Kyoto Prefectural Univ Med, Dept Infect Control & Lab Med, Kamigyo Ku, Kyoto 6028566, Japan
关键词
FIELD GEL-ELECTROPHORESIS; SEQUENCE TYPING SCHEME; ENTEROCOCCUS-FAECIUM; COMPLEXES; SETTINGS; OUTCOMES; HEALTH; BROTH;
D O I
10.1007/s10096-011-1412-x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The purpose of this investigation was to control the post-outbreak prevalence of vancomycin-resistant enterococci (VRE) in the affected Kyoto region. The study period was from 2005 to 2010. Faecal samples were subjected to VRE screening, and vancomycin resistance genes were detected by polymerase chain reaction (PCR). The genotype was determined by pulsed-field gel electrophoresis (PFGE) of genomic DNA digested with I and by multilocus sequence typing (MLST). A VRE control programme was established in 2006, consisting of a laboratory-based faecal VRE screening system, annual surveillance of hospital inpatients and the promotion of adequate infection control measures. -, - and - were detected at 35, 12 and 5 hospitals, respectively. Genotype analysis revealed that all of the vancomycin-resistant isolates obtained since 2005 belonged to ST78, and that clonally related - of ST64 had spread to three hospitals. The rate of faecal VRE carriage among the patients enrolled in the annual surveillance increased until 2007, when it reached 24 (1.2%) of the 2,035 enrolled patients. The rate began to decrease in 2008 and, by 2010, reached a low of 4 (0.17%) of the 2,408 enrolled patients. While VRE did spread within the Kyoto region, the VRE control programme succeeded in controlling the overall VRE spread.
引用
收藏
页码:1095 / 1100
页数:6
相关论文
共 50 条
  • [21] VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM INFECTIONS ON PEDIATRIC WARDS
    Bayraktar, Banu
    Baris, Ayse Bayri
    Bulut, Emin
    Toksoy, Buket
    Palanduz, Ayse
    Aktas, Zerrin
    Kayacan, Cigdem Bal
    Aslan, Turan
    PAEDIATRIA CROATICA, 2011, 55 (03) : 233 - 237
  • [22] Molecular epidemiology of vancomycin-resistant Enterococcus faecium in Argentina
    Corso, Alejandra C.
    Gagetti, Paula S.
    Rodriguez, Marisa M.
    Melano, Roberto G.
    Ceriana, Paola G.
    Faccone, Diego F.
    Galas, Marcelo F.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (01) : 69 - 75
  • [23] Advances in prevention and treatment of vancomycin-resistant Enterococcus infection
    Isenman, Heather
    Fisher, Dale
    CURRENT OPINION IN INFECTIOUS DISEASES, 2016, 29 (06) : 577 - 582
  • [24] Acquisition of vancomycin-resistant enterococci in internal medicine wards
    Cohen, Matan J.
    Adler, Amos
    Block, Colin
    Gross, Ilana
    Minster, Naomi
    Roval, Varda
    Tchakirov, Rachel
    Moses, Allon E.
    Benenson, Shmuel
    AMERICAN JOURNAL OF INFECTION CONTROL, 2009, 37 (02) : 111 - 116
  • [25] Genomic Surveillance of Vancomycin-Resistant Enterococcus faecium Reveals Spread of a Linear Plasmid Conferring a Nutrient Utilization Advantage
    Boumasmoud, Mathilde
    Haunreiter, Vanina Dengler
    Schweizer, Tiziano A.
    Meyer, Lilly
    Chakrakodi, Bhavya
    Schreiber, Peter W.
    Seidl, Kati
    Kuehnert, Denise
    Kouyos, Roger D.
    Zinkernagel, Annelies S.
    MBIO, 2022, 13 (02):
  • [26] Molecular characterization of vancomycin-resistant enterococci in Hangzhou, China
    Qu, Ting-ting
    Chen, Ya-gang
    Yu, Yun-song
    Lv, Huo-xiang
    Dong, Xiao-qin
    Xiao, Zhen
    Gu, Hong-qin
    Li, Lan-juan
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (06) : 1403 - 1405
  • [27] Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children
    Tamma, Pranita D.
    Hsu, Alice J.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2014, 27 (06) : 517 - 527
  • [28] Not All Patients with Vancomycin-Resistant Enterococci Need To Be Isolated
    Sutter, S. Tschudin
    Frei, R.
    Dangel, M.
    Gratwohl, A.
    Bonten, M.
    Widmer, A. F.
    CLINICAL INFECTIOUS DISEASES, 2010, 51 (06) : 678 - 683
  • [29] Use of Oral Vancomycin for Clostridioides difficile Infection and the Risk of Vancomycin-Resistant Enterococci
    Stevens, Vanessa W.
    Khader, Karim
    Echevarria, Kelly
    Nelson, Richard E.
    Zhang, Yue
    Jones, Makoto
    Timbrook, Tristan T.
    Samore, Matthew H.
    Rubin, Michael A.
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (03) : 645 - 651
  • [30] The Increasing Issue of Vancomycin-Resistant Enterococci and the Bacteriocin Solution
    Reinseth, Ingvild S.
    Ovchinnikov, Kirill, V
    Tonnesen, Hanne H.
    Carlsen, Harald
    Diep, Dzung B.
    PROBIOTICS AND ANTIMICROBIAL PROTEINS, 2020, 12 (03) : 1203 - 1217